Literatur
-
1
Bornfeld N, Anastassiou G, Fitzek M et al.
Perspektiven der Ophthalmoonkologie.
Dtsch Arztebl.
2004;
101
A2526-A2535
-
2 Singh A D. Clinical ophthalmic oncology. Philadelphia; Saunders (Elsevier) 2007
-
3
Egan K M, Seddon J M, Glynn R J et al.
Epidemiologic aspects of uveal melanoma.
Surv Ophthalmol.
1988;
32
239-251
-
4
Singh A D, Topham A.
Incidence of uveal melanoma in the United States: 1973–1997.
Ophthalmology.
2003;
110
956-961
-
5
Singh A D, Donoso L A, Jackson L et al.
Familial uveal melanoma: absence of constitutional cytogenic abnormalities in 14 cases.
Arch Ophthalmol.
1996;
114
502-503
-
6
Singh A D, Kalyani P, Topham A.
Estimating the risk of malignant transformation of a choroidal nevus.
Ophthalmology.
2005;
112
1784-1789
-
7
Shields C L, Demirci H, Materin M A et al.
Clinical factors in the identification of small choroidal melanoma.
Can J Ophthalmol.
2004;
39
351-357
-
8
Shields C L, Furuta M, Thangappan A et al.
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.
Arch Ophthalmol.
2009;
127
989-998
-
9
McLean I W, Foster W D, Zimmerman L E, Gamel J W.
Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology.
Am J Ophthalmol.
1983;
96
502-509
-
10
Char D H, Kroll S M, Miller T et al.
Irradiated uveal melanomas: cytopathologic correlation with prognosis.
Am J Ophthalmol.
1996;
122
509-513
-
11
Prescher G, Bornfeld N, Hirche H et al.
Prognostic implications of monosomy 3 in uveal melanoma.
Lancet.
1996;
347
1222-1225
-
12
Young T A, Burgess B L, Rao N P et al.
High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Mol Vis.
2007;
13
2328-2333
-
13
Schoenfield L, Pettay J, Tubbs R R et al.
Variation of monosomy 3 status within uveal melanoma.
Arch Pathol Lab Med.
2009;
133
1219-1222
-
14
Eide N, Walaas L.
Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review.
Acta Ophthalmol.
2009;
87
588-601
-
15
Folberg R, Rummelt V, Parys-Van Ginderdeuren R et al.
The prognostic value of tumor blood vessel morphology in primary uveal melanoma.
Ophthalmology.
1993;
100
1389-1398
-
16
Mueller A J, Freeman W R, Schaller U C et al.
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II.
Ophthalmology.
2002;
109
2207-2214
-
17
Kujala E, Kivela T.
Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
Ophthalmology.
2005;
112
1135-1144
-
18
Damato B.
Treatment of primary intraocular melanoma.
Expert Rev Anticancer Ther.
2006;
6
493-506
-
19
Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1.
Arch Ophthalmol.
1990;
108
1268-1273
-
20
Ossoinig K C, Bigar F, Kaefring S L.
Malignant melanoma of the choroid and ciliary body. A differential diagnosis in clinical echography.
Bibl Ophthalmol.
1975;
83
141-154
-
21
Hasenfratz G.
Intraocular ultrasonic diagnostics.
Klin Monatsbl Augenheilkd.
2008;
225
R103-R116
quiz R17-R20
-
22
Seregard S.
To biopsy or not to biopsy?.
Acta Ophthalmol.
2009;
87
586-587
-
23
Zimmerman L E, McLean I W, Foster W D.
Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.
Br J Ophthalmol.
1978;
62
420-425
-
24
Singh A D, Rennie I G, Kivela T et al.
The Zimmerman-McLean-Foster hypothesis: 25 years later.
Br J Ophthalmol.
2004;
88
962-967
-
25
Diener-West M, Earle J D, Fine S L et al.
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.
Arch Ophthalmol.
2001;
119
969-982
-
26
Bornfeld N.
Proton treatment of uveal melanomas.
Strahlenther Onkol.
2007;
183
1-2
-
27
Bekkering G E, Rutjes A W, Vlassov V V et al.
The effectiveness and safety of proton radiation therapy for indications of the eye: a systematic review.
Strahlenther Onkol.
2009;
185
211-221
-
28
Muacevic A, Nentwich M, Wowra B et al.
Development of a streamlined, non-invasive robotic radiosurgery method for treatment of uveal melanoma.
Technol Cancer Res Treat.
2008;
7
369-374
-
29
Zorlu F, Selek U, Kiratli H.
Initial results of fractionated CyberKnife radiosurgery for uveal melanoma.
J Neurooncol.
2009;
94
111-117
-
30
Zytkovicz A, Daftari I, Phillips T L et al.
Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy.
Phys Med Biol.
2007;
52
5957-5971
-
31
Chuang C F, Larson D A, Zytkovicz A et al.
Peripheral dose measurement for CyberKnife radiosurgery with upgraded linac shielding.
Med Phys.
2008;
35
1494-1496
-
32
Daftari I K, Petti P L, Larson D A et al.
A noninvasive eye fixation monitoring system for CyberKnife radiotherapy of choroidal and orbital tumors.
Med Phys.
2009;
36
719-724
-
33
Hintschich C.
Dermis-fat graft. Possibilities and limitations.
Ophthalmologe.
2003;
100
518-524
-
34
Kivela T, Puusaari I, Damato B.
Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
Ophthalmology.
2003;
110
2235-2244
-
35
Garcia-Arumi J, Zapata M A, Balaguer O et al.
Endoresection in high posterior choroidal melanomas: long-term outcome.
Br J Ophthalmol.
2008;
92
1040-1045
-
36
Finger P T, Kurli M, Reddy S et al.
Whole body PET/CT for initial staging of choroidal melanoma.
Br J Ophthalmol.
2005;
89
1270-1274
-
37
Kujala E, Makitie T, Kivela T.
Very long-term prognosis of patients with malignant uveal melanoma.
Invest Ophthalmol Vis Sci.
2003;
44
4651-4659
-
38
Augsburger J J, Correa Z M, Shaikh A H.
Effectiveness of treatments for metastatic uveal melanoma.
Am J Ophthalmol.
2009;
148
119-127
-
39
Haritoglou I, Wolf A, Maier T et al.
Osteopontin and ‘melanoma inhibitory activity: comparison of two serological tumor markers in metastatic uveal melanoma patients.
Ophthalmologica.
2009;
223
239-243
Prof. Dr. Arthur Mueller
Klinikum Augsburg
Stenlingstraße 2
86156 Augsburg
Phone: 08 21/4 00-25 51
Fax: 08 21/4 00-21 40
Email: Arthur.Mueller@klinikum-augsburg.de
